Your browser doesn't support javascript.
loading
A Low-Cost Open Source Device for Cell Microencapsulation.
Pereira, Miriam Salles; Cardoso, Liana Monteiro da Fonseca; da Silva, Tatiane Barreto; Teixeira, Ayla Josma; Mizrahi, Saul Eliahú; Ferreira, Gabriel Schonwandt Mendes; Dantas, Fabio Moyses Lins; Cotta-de-Almeida, Vinicius; Alves, Luiz Anastacio.
Affiliation
  • Pereira MS; Laboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
  • Cardoso LMDF; Volta Redonda University Center-UniFOA, Av. Paulo Erlei Alves Abrantes, 1325-Três Poços, Volta Redonda 27240-560, Brazil.
  • da Silva TB; Laboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
  • Teixeira AJ; Laboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
  • Mizrahi SE; Laboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
  • Ferreira GSM; National Institute of Technology-INT, Rio de Janeiro Av. Venezuela, 82-Saúde, Rio de Janeiro 20081-312, Brazil.
  • Dantas FML; National Institute of Technology-INT, Rio de Janeiro Av. Venezuela, 82-Saúde, Rio de Janeiro 20081-312, Brazil.
  • Cotta-de-Almeida V; National Institute of Technology-INT, Rio de Janeiro Av. Venezuela, 82-Saúde, Rio de Janeiro 20081-312, Brazil.
  • Alves LA; Laboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
Materials (Basel) ; 13(22)2020 Nov 11.
Article in En | MEDLINE | ID: mdl-33187294
Microencapsulation is a widely studied cell therapy and tissue bioengineering technique, since it is capable of creating an immune-privileged site, protecting encapsulated cells from the host immune system. Several polymers have been tested, but sodium alginate is in widespread use for cell encapsulation applications, due to its low toxicity and easy manipulation. Different cell encapsulation methods have been described in the literature using pressure differences or electrostatic changes with high cost commercial devices (about 30,000 US dollars). Herein, a low-cost device (about 100 US dollars) that can be created by commercial syringes or 3D printer devices has been developed. The capsules, whose diameter is around 500 µm and can decrease or increase according to the pressure applied to the system, is able to maintain cells viable and functional. The hydrogel porosity of the capsule indicates that the immune system is not capable of destroying host cells, demonstrating that new studies can be developed for cell therapy at low cost with microencapsulation production. This device may aid pre-clinical and clinical projects in low- and middle-income countries and is lined up with open source equipment devices.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Materials (Basel) Year: 2020 Document type: Article Affiliation country: Brazil Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Materials (Basel) Year: 2020 Document type: Article Affiliation country: Brazil Country of publication: Switzerland